Farmson’s success and longevity in the pharmaceutical industry are strongly tied to its robust Research & Development (R&D) capabilities. The company operates a dedicated, state-of-the-art R&D center focused on developing innovative, non-infringing processes for both existing and new drug products. This means Farmson’s scientists design novel synthetic routes that avoid patent violations, enabling the company to produce generic APIs cost-effectively once patents expire. The R&D team’s core mission is to continuously improve APIs and directly compressible granules for safer, more efficient, and more affordable drug formulations.

Expertise and Facilities: Farmson’s R&D staff includes highly qualified chemists and engineers experienced in multiple pharmaceutical domains. Key areas of research include analgesics (pain relievers like paracetamol and beyond), central nervous system stimulants (e.g., caffeine and related compounds), anti-diabetic drugs, and other therapeutic segment. The R&D laboratory itself is equipped with modern infrastructure to support multi-scale synthesis – from gram-level experiments up to kilo-scale pilot batches. The facilities feature an array of advanced equipment, such as:

• Synthesis Equipment: Modern fume hood systems for safe chemical handling, a 25-liter autoclave for high-pressure reactions, and an assortment of stainless steel and glass reactors ranging from 20 L to 250 L in volume for scale-up studies. This allows Farmson to simulate full manufacturing conditions and optimize processes before commercial production.
  
• Drying and Formulation: Vacuum tray dryers, hot air ovens, and fluidized bed dryers are available to develop and refine solid forms like powders and granules – crucial for work on Paracetamol DC and other formulation intermediates.
  
• Analytical Instruments: A comprehensive analytical suite including HPLC, UPLC (ultra-performance liquid chromatography), GC (gas chromatography), FTIR (Fourier-transform infrared spectroscopy), and auto-titrators ensures that R&D scientists can thoroughly characterize compounds, identify impurities, and ensure each process meets quality specifications.
  

Innovation and Compliance: Every R&D project at Farmson is carried out with an eye on global regulatory standards. The R&D workflows adhere to ICH guidelines and consider US FDA and EU GMP requirements from the earliest stages of development. This rigorous approach means that processes developed in the lab will scale up to production that can pass regulatory scrutiny in any market. Before any new or improved process is implemented at plant scale, it undergoes thorough in-house validation to ensure consistency and safety.

Farmson’s R&D not only improves internal processes but also extends to collaborative development. The company invites clients and partners to engage in custom API or formulation development. Farmson’s scientists can co-create tailored grades of products or even entirely new products as per a client’s needs. They provide full technical support – from initial concept to pilot batches – helping accelerate the partner’s time to market. This openness to collaboration has made Farmson a preferred partner for companies looking to outsource development of tricky APIs or to customize excipient blends.

Expanding Horizons: A significant thrust of Farmson’s R&D is exploring new APIs beyond paracetamol and caffeine. In fact, Farmson recently established a new R&D center specifically aimed at high-demand APIs and novel molecules to expand its portfolio. This proactive approach ensures Farmson stays ahead of market trends and can diversify into emerging therapeutic areas. The company’s innovation track record was recognized when Farmson received an award for “Outstanding Contribution in Pharma R&D” in 2024, reflecting its dedication to scientific excellence. Such accolades underscore Farmson’s role in advancing pharmaceutical technology.

Overall, R&D at Farmson acts as the engine of innovation and quality enhancement. From optimizing the paracetamol manufacturing route (e.g., adopting the PNCB process for purity to developing specialized grades of caffeine and paracetamol DC, Farmson’s research efforts translate directly into superior products. By focusing on cost-effectiveness and eco-friendly methods, the R&D team also ensures that improvements align with sustainability and affordability – values central to Farmson’s mission. This continuous innovation pipeline enables Farmson to maintain its competitive edge and fulfill its commitment to delivering high-quality, affordable pharmaceuticals to the global market.